MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...
Researchers developed MassiveFold, an enhanced AlphaFold version optimized for parallel processing, which accelerates protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback